Cargando…
Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies
INTRODUCTION: The purpose of the present study was to systematically review the effect of cyclophosphamide treatment on pulmonary function in patients with systemic sclerosis and interstitial lung disease. METHODS: The primary outcomes were the mean change in forced vital capacity and in diffusing c...
Autores principales: | Nannini, Carlotta, West, Colin P, Erwin, Patricia J, Matteson, Eric L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592814/ https://www.ncbi.nlm.nih.gov/pubmed/18937831 http://dx.doi.org/10.1186/ar2534 |
Ejemplares similares
-
Correction: Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies
por: Nannini, Carlotta, et al.
Publicado: (2009) -
Long Term Effects of Cyclophosphamide Treatment on Lung Function and Survival in Scleroderma Patients with Interstitial Lung Disease
por: Mittoo, S, et al.
Publicado: (2011) -
Primary Sjögren's syndrome 1976–2005 and associated interstitial lung disease: a population-based study of incidence and mortality
por: Nannini, Carlotta, et al.
Publicado: (2013) -
Scleroderma-related interstitial lung disease
por: Suliman, Sally, et al.
Publicado: (2017) -
Mycophenolate Mofetil versus Oral Cyclophosphamide in Scleroderma-related Interstitial Lung Disease: Scleroderma Lung Study II (SLS-II), a double-blind, parallel group, randomised controlled trial
por: Tashkin, Donald P, et al.
Publicado: (2016)